Mathieu Métifiot
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 32
- HIV Research and Treatment 32
-
- HIV/AIDS drug development and treatment 40
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Yves G. Pommier (30 shared papers)Christophe Marchand (24 shared papers)Kasthuraiah Maddali (14 shared papers)Stephen H. Hughes (16 shared papers)Marie‐Line Andréola (17 shared papers)Steven J. Smith (12 shared papers)Samir Amrane (2 shared papers)Simón Litvak (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (9 papers)Nucleic Acids Research (4 papers)ACS Chemical Biology (3 papers)Molecules (3 papers)Scientific Reports (3 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Mathieu Métifiot
50 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 73
- Virology 869
- Infectious Diseases 1.1k
- Molecular Biology 1.0k
- Organic Chemistry 331
- Epidemiology 190
Countries citing papers authored by Mathieu Métifiot
This map shows the geographic impact of Mathieu Métifiot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Métifiot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Métifiot more than expected).
Fields of papers citing papers by Mathieu Métifiot
This network shows the impact of papers produced by Mathieu Métifiot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Métifiot. The network helps show where Mathieu Métifiot may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathieu Métifiot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 222 | |
| 2 | 2014 | 203 | |
| 3 | 2010 | 91 | |
| 4 | 2009 | 81 | |
| 5 | 2015 | 72 | |
| 6 | 2011 | 68 | |
| 7 | 2010 | 62 | |
| 8 | 2013 | 57 | |
| 9 | 2013 | 50 | |
| 10 | 2013 | 50 | |
| 11 | 2014 | 47 | |
| 12 | 2017 | 46 | |
| 13 | 2011 | 45 | |
| 14 | 2013 | 43 | |
| 15 | 2011 | 40 | |
| 16 | 2012 | 40 | |
| 17 | 2015 | 40 | |
| 18 | 2014 | 38 | |
| 19 | 2016 | 38 | |
| 20 | 2014 | 34 |
About Mathieu Métifiot
Mathieu Métifiot is a scholar working on Virology, Infectious Diseases, Molecular Biology, Epidemiology and Organic Chemistry, having authored 51 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (40 papers), HIV Research and Treatment (32 papers), Biochemical and Molecular Research (26 papers), Click Chemistry and Applications (5 papers), Advanced biosensing and bioanalysis techniques (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Mosquito-borne diseases and control (3 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Virology (869 citations), Infectious Diseases (1.1k citations), Molecular Biology (1.0k citations), Organic Chemistry (331 citations) and Epidemiology (190 citations). Mathieu Métifiot has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Yves G. Pommier, Christophe Marchand, Kasthuraiah Maddali, Stephen H. Hughes, Marie‐Line Andréola, Steven J. Smith, Samir Amrane, Simón Litvak, Peter Cherepanov and Xue Zhi Zhao. Their work appears in journals such as Journal of Medicinal Chemistry, Nucleic Acids Research, ACS Chemical Biology, Molecules and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.